Mary Agnes Wilderotter Sells 3,000 Shares of Docusign (NASDAQ:DOCU) Stock

03 Apr 2026, 22:42 by Mitch Edgeman · The Markets Daily

Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director Mary Agnes Wilderotter sold 3,000 shares of Docusign stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $48.15, for a total transaction of $144,450.00. Following the completion of the sale, the director directly owned 59,803 shares of the company’s stock, valued at approximately $2,879,514.45. The trade was a 4.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Docusign Stock Performance

DOCU stock remained flat at $48.37 during midday trading on Friday. 3,274,561 shares of the company’s stock were exchanged, compared to its average volume of 5,249,164. The firm has a 50 day simple moving average of $47.58 and a two-hundred day simple moving average of $62.08. Docusign Inc. has a fifty-two week low of $40.16 and a fifty-two week high of $94.67. The firm has a market capitalization of $9.40 billion, a P/E ratio of 32.68, a price-to-earnings-growth ratio of 1.88 and a beta of 0.99.

Docusign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.06. The firm had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. Docusign had a net margin of 9.60% and a return on equity of 16.86%. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period last year, the firm earned $0.86 earnings per share. On average, equities research analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign declared that its Board of Directors has authorized a stock buyback plan on Tuesday, March 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 21% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board believes its shares are undervalued.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near‑term analyst-driven directional risk moderate. MarketBeat analyst coverage
Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5‑1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5‑1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
Negative Sentiment: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4

Analyst Ratings Changes

A number of analysts have commented on DOCU shares. Citigroup decreased their price objective on Docusign from $120.00 to $99.00 and set a “buy” rating for the company in a report on Wednesday, March 18th. Wells Fargo & Company cut their target price on Docusign from $75.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Wednesday, March 18th. BTIG Research reiterated a “buy” rating and set a $70.00 price target on shares of Docusign in a report on Wednesday, March 18th. JPMorgan Chase & Co. lowered their price target on Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Finally, UBS Group dropped their price objective on Docusign from $75.00 to $54.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Five investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $64.67.

Get Our Latest Research Report on Docusign

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in shares of Docusign by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company’s stock worth $1,558,986,000 after buying an additional 225,525 shares during the last quarter. State Street Corp increased its holdings in Docusign by 0.9% during the fourth quarter. State Street Corp now owns 8,193,805 shares of the company’s stock worth $560,456,000 after buying an additional 77,008 shares during the last quarter. Capital World Investors increased its holdings in Docusign by 38.1% during the fourth quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after buying an additional 1,603,900 shares during the last quarter. Geode Capital Management LLC raised its position in Docusign by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company’s stock worth $278,665,000 after acquiring an additional 18,873 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Docusign by 8.1% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,343,613 shares of the company’s stock worth $228,703,000 after acquiring an additional 251,639 shares during the period. Institutional investors own 77.64% of the company’s stock.

Docusign Company Profile

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.